We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pfizer and BioNTech released new study results yesterday indicating their COVID-19 vaccine would likely induce immunity for all 10 mutations on the spike protein of the SARS-CoV-2 viral strain identified in the UK, but other research suggests the vaccine might not be effective against new variants. Read More
A new survey has found that interactions between U.S. family medicine residencies and the pharma industry in 2019 continued a decade-long downward trend. Read More
Mylan and three pharmacy benefit managers — CVS Caremark, Express Scripts and OptumRx — must face a class-action lawsuit claiming that the drugmaker paid bribes and kickbacks to the three companies to ensure a monopoly market for EpiPen, a federal judge has ruled. Read More
What would have been the biggest patent verdict in history will not be reinstated in favor of Merck, after the Supreme Court Tuesday declined to hear the pharma giant’s last appeal. Read More
Maryland’s state Senate has voted to overrule Gov. Larry Hogan’s veto of a bill to fund the state’s Prescription Drug Affordability Board (PDAB), an independent entity meant to cap prices for costly drugs in the state by 2022. Read More
The European Union (EU) and Canada will see temporary reductions in shipments of the Pfizer/BioNTech COVID-19 vaccine as Pfizer upgrades its Belgian facility to meet a goal of producing 2 billion doses annually, raising concerns as global coronavirus cases surge. Read More